Boston Scientific (BSX) shareholders could soon take the lead in a potential securities fraud lawsuit. A recent press release out of New York highlighted the opportunity for investors to spearhead legal action against the global medical device company.

Merit Financial Group LLC has expanded its holdings in Boston Scientific Corporation by 12% during the second quarter. According to an SEC filing, the firm added 14,508 shares to reach a total of 134,928 shares of the medical equipment giant.

Oliver Lagore Vanvalin Investment Group disclosed a new stake in Boston Scientific Corporation, buying 371 shares in the second quarter. The investment, valued at approximately $37,000, was noted in a filing with the Securities and Exchange Commission.